One of the biggest biotech success stories is among the companies featured in the afternoon sessions here at the BioCentury/Thomson Reuters investment conference... Read More

A little more than 24 hours after announcing its big, lucrative Alzheimer's drug partnership with Pfizer, Medivation had the lead-off position (I wonder if they told organizers they'd be a newsmaker) at today's BioCentury/Thomson Reuters biotech investment conference in New York City... Read More

Andrew Puzder got off the plane only a couple of hours before I sat down to talk to him... Read More

While I was on the "New England Journal of Medicine" Web site yesterday preparing my reports for today about the embargoed articles, I noticed a banner ad at the top of the homepage from Eli Lilly saying something along the lines of, "Coming Soon: Effient (Prasugrel)." ... Read More

Emerging markets investment guru Mark Mobius told CNBC's Asia Squawk Box that he's bullish on Thailand as an investment destination long term... Read More